Keyword Connections

influenza vaccine

Journals

2

1 International journal of medical informatics

2 Vaccine

Research Groups

0

No Research Group Connected

Bibliographies

49

1 Influenza vaccine coverage and predictors of vaccination among aged care workers in Sydney Australia.

2 hidroxicloroquina na hemossiderose pulmonar idiopática: caso clínico hydroxychloroquine in pediatric idiopathic pulmonary hemosiderosis: a case report

3 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

4 Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public

5 Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans.

6 A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.

7 Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay

8 Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis.

9 Health information technology use and influenza vaccine uptake among US adults.

10 Pregnancy-related immune suppression leads to altered influenza vaccine recall responses.

11 Workshop report: Experimental animal models for universal influenza vaccines.

12 High performance of rapid influenza diagnostic test and variable effectiveness of influenza vaccines in Mexico.

13 Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.

14 Food additives as novel influenza vaccine adjuvants

15 Will the public take a universal influenza vaccine?: the need for social and behavioral science research.

16 Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis.

17 Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

18 Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain.

19 Shades of gray in vaccination decisions - Understanding community pharmacists' perspectives of, and experiences with, influenza vaccine hesitancy in Ontario, Canada.

20 Impact of influenza vaccine-modified infectivity on attack rate, case fatality ratio and mortality.

21 Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development.

22 Safety and Impact on Training of the Influenza Vaccines in Elite Athletes Participating in the Rio 2016 Olympics.

23 Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort

24 Influenza vaccine: A viable option to protect pregnant women and infants from seasonal flu: A retrospective hospital-based study in India

25 Rheumatoid Arthritis and Swine Influenza Vaccine: A Case Report

26 THE COMPARISON OF INFLUENZA VACCINE EFFICACY ON RESPIRATORY DISEASE AMONG IRANIAN PILGRIMS IN THE 2003 AND 2004 SEASONS

27 EVALUATION OF OIL BASED AVIAN INFLUENZA VACCINE (H5NI) PREPARED WITH DIFFERENT CONCENTRATIONS OF ADJUVANT

28 Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan

29 Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017

30 Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by instituto Butantan

31 A plant-based system for rapid production of influenza vaccine antigens.

32 Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine

33 Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults

34 Potential Antigenic Mismatch of the H3N2 Component of the 2019 Southern Hemisphere Influenza Vaccine

35 Immunogenicity of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod: A Double Blind Randomized Controlled Trial

36 pandemic influenza vaccines – the challenges

37 seropositivity of influenza a h1ni in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic

38 immunogenicity and safety of an as03a-adjuvanted h5n1 influenza vaccine in a taiwanese population

39 relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review

40 a review of influenza vaccine immunogenicity and efficacy in hiv-infected adults

41 not for industry only: medical students and office-based academic detailing the pivot (pregnant women influenza vaccine optimization team) initiative

42 segurança, imunogenicidade e eficácia da vacina contra o vírus influenza em crianças safety, immunogenicity and efficacy of influenza vaccine in children

43 immune history and influenza vaccine effectiveness

44 adverse drug events monitoring of live attenuated pandemic influenza vaccine

45 clinical advances in viral-vectored influenza vaccines

46 seasonal influenza vaccine – view of the elderly

47 immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents

48 yeast surface-displayed h5n1 avian influenza vaccines

49 Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial